Exploration of novel plumbagin derivatives as anti‐liver cancer inhibitors of VEGFR‐2: Designing, ADMET, QSAR models, and molecular docking
- 25 July 2025
- journal article
- Published by Wiley in Vietnam Journal of Chemistry
- Vol. 64 (2) , 268-278
Abstract
A series of novel compounds of plumbagin (PLG) derivatives from Plumbago Zeylanica Linn were identified in this investigation as potential inhibitors against the HepG2 cell line‐derived liver cancer. The quantitative structure‐activity relationship (QSAR) models were used to design novel plumbagin derivatives. The QSAR models were constructed using multiple linear regression (MLR) and artificial neural network (ANN) techniques based on the chemical descriptors and the IC 50 values of experimental plumbagin derivatives. As a result, six descriptors that are key features of the QSAR MLR model satisfy the following statistical requirements: R 2 train = 0.835, R 2 adj = 0.818, and Q 2 LOO = 0.787. The QSAR ANN model with the architecture of I(6)‐HL(5)‐O(1) was constructed based on variables of the QSAR MLR model, with statistical data: R 2 train = 0.988; Q 2 validation = 0.937, and R 2 test = 0.964. Consequently, twenty plumbagin derivatives (PLG1‐PLG20) within the applicability domain (AD) exhibited promising IC 50 values as calculated by both QSAR models, of which 11 derivatives met the criteria of drug‐likeness by using Lipinski‐5 and Veber rules. The derivatives underwent ADME analysis to assess their drug‐likeness. Subsequently, they were docked into the VEGFR receptor to identify potential inhibitors, of which 9 of 20 PLG derivatives are potential inhibitors for anti‐liver cancer. The findings may be helpful in the development of novel medications for the treatment of liver cancer.Keywords
This publication has 16 references indexed in Scilit:
- Novel anticancer hybrids from diazen-1-ium-1,2-diolate nitric oxide donor and ROS inducer plumbagin: Design, synthesis and biological evaluationsEuropean Journal of Medicinal Chemistry, 2018
- Novel NO-releasing plumbagin derivatives: Design, synthesis and evaluation of antiproliferative activityEuropean Journal of Medicinal Chemistry, 2017
- Synthesis and molecular docking study of novel alizarin derivatives containing phosphoryl amino acid moiety as potential antitumor agentsMedicinal Chemistry Research, 2017
- Engineered jadomycin analogues with altered sugar moieties revealing JadS as a substrate flexible O-glycosyltransferaseApplied Microbiology and Biotechnology, 2017
- Synthesis and antitumor activities of novel rhein α-aminophosphonates conjugatesBioorganic & Medicinal Chemistry Letters, 2014
- Preparation of novel antiproliferative emodin derivatives and studies on their cell cycle arrest, caspase dependent apoptosis and DNA binding interactionPhytomedicine, 2013
- Optimization of parameters for semiempirical methods VI: more modifications to the NDDO approximations and re-optimization of parametersJournal of Molecular Modeling, 2012
- Beware of q2!Journal of Molecular Graphics and Modelling, 2002
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Advanced Drug Delivery Reviews, 2001
- Neural Networks in ChemistryAngewandte Chemie International Edition, 1993